Compass Therapeutics (CMPX) Other Gross PP&E Adjustments (2023 - 2025)
Historic Other Gross PP&E Adjustments for Compass Therapeutics (CMPX) over the last 3 years, with Q3 2025 value amounting to -$2.7 million.
- Compass Therapeutics' Other Gross PP&E Adjustments fell 114749.03% to -$2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.7 million, marking a year-over-year decrease of 114749.03%. This contributed to the annual value of -$3.9 million for FY2024, which is 24654.02% down from last year.
- Per Compass Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at -$2.7 million for Q3 2025, which was down 114749.03% from -$3.1 million recorded in Q2 2025.
- In the past 5 years, Compass Therapeutics' Other Gross PP&E Adjustments registered a high of $6.0 million during Q2 2024, and its lowest value of -$3.9 million during Q4 2024.
- Moreover, its 3-year median value for Other Gross PP&E Adjustments was $2.7 million (2023), whereas its average is $1.8 million.
- Per our database at Business Quant, Compass Therapeutics' Other Gross PP&E Adjustments surged by 2790.12% in 2024 and then plummeted by 114749.03% in 2025.
- Quarter analysis of 3 years shows Compass Therapeutics' Other Gross PP&E Adjustments stood at $2.7 million in 2023, then plummeted by 246.54% to -$3.9 million in 2024, then soared by 31.12% to -$2.7 million in 2025.
- Its last three reported values are -$2.7 million in Q3 2025, -$3.1 million for Q2 2025, and $225000.0 during Q1 2025.